SCHEMBL4503333

SCHEMBL4503333

CC(Oc1ccccc1)C(=O)Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 8/20 0.58
HDAC6 Q9UBN7 4/20 0.52
GSK3A P49840 2/20 0.52
FGFR1 P11362 2/20 0.51
FGFR2 P21802 2/20 0.51
FGFR3 P22607 2/20 0.51
CYP1A2 P05177 1/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
ATM Q13315 1/20 0.49
ADORA3 P0DMS8 1/20 0.48
ADORA2A P29274 1/20 0.48
ADORA1 P30542 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CASP6 P55212 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4496312 0.94 GSK3B (0.60) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4485505 0.92 GSK3B (0.59) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4487636 0.91 HDAC6 (0.52) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4490547 0.91 GSK3B (0.58) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4505011 0.90 HDAC6 (0.59) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4497946 0.90 GSK3B (0.53) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4505048 0.89 GSK3B (0.49) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4480882 0.89 GSK3B (0.59) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4494179 0.89 HDAC6 (0.56) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4486296 0.88 HDAC6 (0.49) GSK3BHDAC6GSK3AFGFR1FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632854-B2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2009-12-15 US claimed